CoChat

Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort

Tosun, Duygu, Chen, Yun-Fei, Yu, Peng, Sundell, Karen L., Suhy, Joyce, Siemers, Eric, Schwarz, Adam J., Weiner, Michael W., Alzheimer's Disease Neuroimaging Initiative · 2016 · Alzheimer's & Dementia
Cited by 27

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Introduction: Mild‐Alzheimer's disease (AD) subjects without significant Aβ pathology represent a confounding finding for clinical trials because they may not progress clinically on the expected trajectory, adding variance into analyses where slowing of progression is being measured. Methods: A prediction model based on structural magnetic resonance imaging (MRI) in combination with baseline demographics and clinical measurements was used to impute Aβ status of a placebo‐treated mild‐AD sub‐cohort (N = 385) of patients participating in global phase 3 trials. The clinical trajectories of this cohort were evaluated over 18 months duration of the trial, stratified by imputed Aβ status within a mixed‐model repeated measures statistical framework. Results: In the imputed Aβ‐positive cohort, both cognitive (ADAS‐Cog 14 and MMSE) and functional (ADCS‐iADL) measures declined more rapidly than in the undifferentiated population. Discussion: Our results demonstrate imputing Aβ status from MRI scans in mild‐AD subjects may be a useful screening tool in global clinical trials if amyloid measurement is not available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2016.03.009

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 27

Metadata

Authors
Tosun, D., Chen, Y.-F., Yu, P., Sundell, K. L., Suhy, J., Siemers, E., Schwarz, A. J., Weiner, M. W., & Initiative, A. D. N.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2016-04-21
Volume
12
Issue
9
Pages
977-986
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2339392274
Cited by
27
References
9
FWCI
0.78
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort. https://app.cochat.ai/papers/10.1016/j.jalz.2016.03.009
The paper
Tosun, D., Chen, Y.-F., Yu, P., Sundell, K. L., Suhy, J., Siemers, E., Schwarz, A. J., Weiner, M. W., & Initiative, A. D. N. (2016). Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2016.03.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.